Single IRB Policy For Multi-Site Trials May Soon Get White House OK; NCI Hopeful

The White House appears close to finalizing a policy that would allow multi-site clinical trials to use only one institutional review board, which National Cancer Institute and other officials think could speed up and improve the process.